Phillip O Livingston

Phase I Study of Abagovomab in Patients with Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

A. Iasonos, P. Sabbatini, K. Odunsi, 2006, Clinical Cancer Research.

Immunological validation of the EpitOptimizer program for streamlined design of heteroclitic epitopes.

J. Wolchok, A. Houghton, P. Gregor, 2007, Vaccine.